2008 annual financial data

Regeneron Pharmaceuticals, Inc. 2008 Operating margin

Regeneron Pharmaceuticals, Inc. 2008 operating margin with verified reported va…

Direct answer

Operating margin was -37.67%.

Operating income was -89,830,000 USD and net income was -82,710,000 USD.
Operating cash flow was -89,086,000 USD.

Get free Regeneron Pharmaceuticals, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
238,457,000 USD
Operating income
-89,830,000 USD
Net income
-82,710,000 USD
Operating cash flow
-89,086,000 USD